Hepatobiliary Cancers Panel - Disclosures
|
Panel Member
|
Thomas Abrams MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Aijaz Ahmed MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Mehmet Akce MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Daniel Anaya MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Robert Anders MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Chandrakanth Are MBA, MBBS, FACS, FRCS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Lydia Aye DO |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Melinda Bachini |
|
Product/Speakers Bureau
|
| ASCO |
|
Date Completed
|
02/15/2025 |
|
Panel Member
|
Marshall Baker MD, MBA |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Al Benson III MD, FACP, FASCO |
|
Grant/Research Support
|
| AbbVie, Inc. | Amgen Inc. | Apexigen | Artemida | Cardiff Oncology | Elevar Therapeutics | Infinity Pharmaceuticals, Inc | ITM Solucin | Janssen Pharmaceutica Products, LP | MedImmune Inc. | Merck & Co., Inc. | Nathan Cummings Foundation | Pfizer Inc. | Rafael Pharmaceuticals | St. Pharma Co. Ltd | SynCore Biotechnology | Tyme Techologies Inc. |
|
Date Completed
|
07/19/2024 |
|
Panel Member
|
David Binder MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Marian Birkeland PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Nicole Blankenhorn |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Daniel Brown MD, FSIR |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Adam Burgoyne MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Jason Castellanos MD, MS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Jordan Cloyd MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Darren Cullinan MD, MSCI |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Michael D'Angelica MD, FACS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Joseph Franses MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Evan Glazer MD, PhD, FACS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kristina Gregory MSN, RN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Evelyn Handel PharmD, BCOP, BCPS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
William Harris MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Brianna Herron PharmD, BCOP, BCPS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Erin Hesler |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Cindy Hochstetler PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Lawrence Jennings MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Robin Kelley MD |
|
Grant/Research Support
|
| Agios, Inc. | AstraZeneca Pharmaceuticals LP | Bayer HealthCare | Bristol Myers Squibb | Compass Therapeutics | Eli Lilly and Company | Exelixis Inc. | Genentech, Inc. | Merck & Co., Inc. | Novartis Pharmaceuticals Corporation | Roche Laboratories, Inc. | Taiho Pharmaceuticals Co., Ltd. | Tyra Biosciences, Surface Oncology, Relay Therapeutics, Partner Therapeutics, QED |
|
Date Completed
|
06/20/2024 |
|
Panel Member
|
Sajid Khan MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Matthew Levine MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Laleh Melstrom MD, MS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Svitlana Ostanina PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Manisha Palta MD |
|
Grant/Research Support
|
| Merck & Co., Inc. | Varian Medical Systems, Inc. |
|
Royalty Income
|
| UpToDate |
|
Date Completed
|
08/14/2024 |
|
Panel Member
|
Donna Powell DHSc, CMD, RT(T) |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Steven Raman MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Tim Rinehart |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Sean Ronnekleiv-Kelly MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Vaibhav Sahai MBBS, MS |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Ryan Schonfeld BA |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Kevin Stephans MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Bettyanne Sunderland BSN, OCN |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Samantha Tamburro BSN, RN, CPON |
|
Salary
|
| Flatiron Health, Inc. |
|
Date Completed
|
10/24/2024 |
|
Panel Member
|
Kannan Thanikachalam MD |
|
Equity Interest/Stock Options
|
| Agenus | ALX Oncology | MiNK Therapeutics | Moderna | Pfizer Inc. |
|
Date Completed
|
04/01/2025 |
|
Panel Member
|
Anita Turk MD |
|
Grant/Research Support
|
| Eli Lilly and Company | Merck & Co., Inc. |
|
Date Completed
|
07/29/2024 |
|
Panel Member
|
Jean-Nicolas Vauthey MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Alan Venook MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Motoyo Yano MD, PhD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
|
Panel Member
|
Adam Yopp MD |
|
Product/Speakers Bureau
|
| Genentech, Inc. |
|
Date Completed
|
09/18/2024 |
|
Panel Member
|
Ken Zhao MD |
| The faculty listed above have no relevant financial relationship(s) with ineligible companies to disclose. |
